PharmaCyte Biotech, Inc. (PMCB) Financials

PMCB Assets vs Liabilities

DateAssetsLiabilities
2023-10-31 78.9 million 20.8 million
2023-07-31 79.9 million 20.4 million
2023-04-30 73.3 million 586581
2023-01-31 78.0 million 827834

PMCB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-10-31 -2.0 million ?
2023-07-31 342959 ?
2023-04-30 -288388 -638072
2023-01-31 -541701 629932

PMCB Net Income

No data available :(

PMCB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-10-31 73.4 million - -
2023-07-31 74.7 million - -
2023-04-30 68.0 million - -
2023-01-31 72.6 million - -

PMCB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-10-31 8.8 million
2023-07-31 12.6 million
2023-04-30 17.8 million
2023-01-31 19.0 million

PMCB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-10-31 - 82033 1.1 million -
2023-07-31 - 104483 1.7 million -
2023-04-30 - 85874 817409 -
2023-01-31 - 45393 1.5 million -

PMCB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-10-31 - -
2023-07-31 - -
2023-04-30 - -
2023-01-31 - -

PMCB

Price: $2.11

52 week price:
1.92
3.23

Earnings Per Share: -1.48 USD

P/E Ratio: -2.48

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 64200

Market Capitalization: 19.1 million

Links: